Sep 30, 2025 15:42
PCVX - Vaxcyte, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 47.55 0.5 (1.04%) | -0.02 (-0.03%) | -0.13 (-0.26%) | -0.88 (-1.79%) | --- | 0.5 (1.04%) | --- | --- |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -1.22
- Diluted EPS:
- -1.22
- Basic P/E:
- -39.3811
- Diluted P/E:
- -39.3811
- RSI(14) 1m:
- 36.36
- VWAP:
- 48.06
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Aug 21, 2025 17:00
Aug 07, 2025 00:19
Mar 31, 2025 12:56
Jan 30, 2025 16:51
Jan 01, 2025 09:27
Sep 05, 2024 03:58
Sep 03, 2024 20:01
Sep 03, 2024 13:40
Sep 02, 2024 22:40